Acute Hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction:: The ECLIPSE international, multicenter, randomized, placebo-controlled trial

被引：6

作者：

Udelson, James E. ^{[1
]}

Orlandi, Cesare ^{[2
]}

Ouyang, John ^{[2
]}

Krasa, Holly ^{[2
]}

Zimmer, Christopher A. ^{[2
]}

Frivold, Geir ^{[3
]}

Haught, W. Herbert ^{[4
]}

Meymandi, Sheba ^{[5
]}

Wedge, Patricia ^{[6
]}

Konstam, Marvin M. ^{[1
]}

Gheorghiade, Mihai ^{[7
]}

机构：

[1] Tufts Univ New England Med Ctr, Boston, MA USA

[2] Otsuka Amer Pharmaceut Inc, Rockville, MD USA

[3] VA Loma Linda Healthcare Syst, Loma Linda, CA USA

[4] Ctr Head, Huntsville, AL USA

[5] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA

[6] Cardiovasc Clin Trials, Boston, MA USA

[7] Northwestern Univ, Sch Med, Chicago, IL 60611 USA

来源：

JOURNAL OF CARDIAC FAILURE | 2007年 / 13卷 / 09期

关键词：

D O I：

10.1016/j.cardfail.2007.10.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：793 / 794

页数：2

共 50 条

[21] Hemodynamic effects of sildenafil citrate in patients with pulmonary arterial hypertension: Results of a multicenter, international, randomized, double blind, placebo-controlled trial
Barst, RJ
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 9A - 10A
[22] Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure -: Results from a double-blind, randomized trial
Gheorghiade, M
Niazi, I
Ouyang, J
Czerwiec, F
Kambayashi, J
Zampino, M
Orlandi, C
CIRCULATION, 2003, 107 (21) : 2690 - 2696
[23] Acute and chronic therapeutic impact of a vasopressin 2 antagonist in congestive heart failure (ACTIV in CHF): A placebo-controlled trial in patients hospitalized with heart failure
Gheorghiade, M
O'Connor, CM
Adams, KF
Gattis, WA
Barbagelata, A
Elkayam, U
McGrew, F
Ghali, JK
Benza, RL
Klapholz, M
Orlandi, C
CIRCULATION, 2003, 108 (21)
[24] Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure
Gheorghiade, M
Gattis, WA
Barbagelata, A
Adams, KF
Elkayam, U
Orlandi, C
O'Connor, CM
AMERICAN HEART JOURNAL, 2003, 145 (02) : S51 - S54
[25] Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome Study with Tolvaptan (EVEREST)
Gheorghiade, M
Orlandi, C
Burnett, JC
Demets, D
Grinfeld, L
Maggioni, A
Swedberg, K
Udelson, JE
Zannad, F
Zimmer, C
Konstam, MA
JOURNAL OF CARDIAC FAILURE, 2005, 11 (04) : 260 - 269
[26] Vasopressin V2 receptor blockade versus fluid restriction in the treatment of hyponatremia:: Results from a multicenter randomized controlled trial
Gheorghiade, M
Orlandi, C
Gottlieb, S
Corder, C
Udelson, JE
Ouyang, J
Konstam, MA
CIRCULATION, 2001, 104 (17) : 438 - 438
[27] Effects of lixivaptan, a novel vasopressin v2 receptor antagonist, in chronic heart failure: Results front a double-blind, placebo-controlled, multiple-dose study
Abraham, William
Goldsmith, Steven
Gottlieb, Stephen
JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S71 - S71
[28] A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo-controlled trial
Wong, F
Blei, AT
Blendis, LM
Thuluvath, PJ
HEPATOLOGY, 2003, 37 (01) : 182 - 191
[29] Randomized, placebo-controlled trial of tolvaptan, a novel V2-receptor antagonist, in hyponatremia: Results of the SALT 2 trial with emphasis on efficacy and safety in cirrhosis
Afdhal, N
Cardenas, A
Gines, P
Gross, P
Verbalis, J
Berl, T
Schrier, R
Bichet, D
Wagoner, L
Ouyang, J
Orlandi, C
Czerwiec, F
HEPATOLOGY, 2005, 42 (04) : 756A - 756A
[30] A phase III, multicenter, randomized, double-blind, placebo-controlled study for efficacy and safety of short-tem tolvaptan usage in patients with acute decompensated heart failure
Lin, Y. H.
Hwang, J. J.
Tseng, C. D.
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 7 - 8

← 1 2 3 4 5 →